Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease;Korelacja stȩżenia białka C-reaktywnego mierzonego metoda̧ o wysokiej czułości z nasileniem zmian miażdżycowych w tȩtnicach wieńcowych u mȩżczyzn z objawami choroby niedokrwiennej serca

Polski Merkuriusz Lekarski

Volumn 18, Issue 107, 2005, Pages 511-515

  Piechota, Wiktor ^a   Piechota, Wiesław ^b  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Atherosclerosis; C reactive porotein (CRP); Coronary angiography; Ischemic heart disease

Indexed keywords

C REACTIVE PROTEIN; STATINE DERIVATIVE; BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ANGIOCARDIOGRAPHY; ARTERIAL SEGMENT SCORE; ARTERY ENDOTHELIUM; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION COEFFICIENT; DIAGNOSTIC KIT; FRIESINGER SCORE; GENSINI SCORE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUMBER OF VESSELS DISEASED SCORE; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; METABOLISM; PREDICTION AND FORECASTING;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ARTERIOSCLEROSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 20144379426     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Biasucci L.M., Liuzzo G., Buffon A. i wsp.: The variable role of inflammation in acute coronary syndromes and in restenosis. Semin. Interv. Cardiol., 1999, 4, 105-110.
2. Biasucci L.M., Liuzzo G., Fantuzzi G. i wsp.: Increasing levels of interleukin (IL)-1RA and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation, 1999, 99, 2079-2084.
3. Biasucci L.M., Vitelli A., Liuzzo G. i wsp.: Elevated levels of interleukin-6 in unstable angina. Circulation, 1996, 94, 874-877.
4. Buffon A., Liuzzo G., Biasucci L.M. i wsp.: Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J. Am. Coll. Cardiol., 1999, 34, 1512-1521.
5. Cleland S.J., Sattar N., Petrie J.R. i wsp.: Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin. Sci. (Colch), 2000, 98, 531-535.
6. Cybulsky M., Gimbrone M.A. Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science, 1991, 251, 788-791.
7. Danesh J., Collins R., Appleby P. i wsp.: Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA, 1998, 279, 1477-1482.
8. Danesh J., Whincup P., Walker M. i wsp.: Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ, 2000, 321, 199-204.
9. Ernst E., Resch K.L.: Fibrynogen as a cardiovascular risk factor: a meta-analisis and review of the literature. Ann. Intern. Med., 1993, 118, 956-963.
10. Filipiak K.J., Tarchalska-Kryńska B., Opolski G.: Metaloproteinazy jako alternatywny układ remodelingu. Kardiol. Pol., 2000, 53, suppl. 3, 83-87.
11. Haverkate F., Thompson S.G., Pyke S.D.M. i wsp.: Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet, 1997, 349, 462-467.
12. Hoffmeister A., Rothenbacher D., Bazner U. i wasp.: Role of novel markers of inflammation in patients with stable coronary heart disease. Am. J. Cardiol., 2001, 87, 262-266.
13. rd, 1999.
14. Lagrand W.K., Visser C.A., Hermens W.T. i wsp.: C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation, 1999, 100, 96-102.
15. Liuzzo G., Biasucci L.M., Gallimore J.R. i wsp.: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N. Engl. J. Med., 1994, 331, 417-424.
16. Liuzzo G., Buffon A., Biasucci L.M. i wsp.: Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation, 1998, 98, 2370-2376.
17. Milazzo D., Biasucci L.M., Luciani N. i wsp.: Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am. J. Cardiol., 1999, 84, 459-461.
18. Mori T., Sasaki J., Kawaguchi H. i wsp.: Serum glycoproteins and severity of coronary atherosclerosis. Am. Heart J., 1995, 129, 234-238.
19. Osborne L.: Leukocyte adhesion to endothelium in inflammation. Cell, 1990, 62, 3-6.
20. Pearson T.A., Mensah G.A., Alexander R.W. i wsp.: AHA/CDC Scientific Statement. Markers of Inflammation and Cardiovascular DiseaseApplication to Clinical and Public Health Practice. A Statement for Healthcare Professionals From the Centers for DiseaseControl and Prevention and the American Heart Association. Circulation, 2003, 107, 499-511.
21. Piechota W.T., Piechota W.N.: Białko C-reaktywne ïwysokiej czułości w ocenie zagrożenia chorobami układu kra̧żenia. Dade Behring Diagnostics. Warszawa. 2001.
22. Ridker P.M., Cushman M., Stampfer M.J. i wsp.: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med., 1997, 336, 973-979.
23. Ridker F., Rifai N., Pfeffer M. i wsp.: inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation, 1998, 98, 839-844.
24. Ringqvist I., Fisher L.D., Mock M. i wsp.: Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J. Clin. Invest, 1983, 71, 1854-1866.
25. Roberts W.L., Sedrick R., Moulton L. i wsp.: Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin. Chem., 2000, 46, 461-468.
26. Ross R.: Mechanisms of disease - atherosclerosis- an inflammatory disease. N. Engl. J. Med., 1999, 340, 115-126.
27. Ross R.: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature, 1993, 362, 801-809.
28. Silverman L.M. Christenson R.H.: Aminoacids and proteins. Tietz textbook of clinical chemistry, (ed. Burtis C.A., Ashwood E.R.). W.B. Saunders Company. Philadelphia. London. 1994, 625-734.
29. Stary H.C.: Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis, 1989, 9, 119-132.
30. Versaci F., Gaspardone A., Tomai F. i wsp.: Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am. J. Cardiol., 2000, 85, 92-95, 8.
31. van der Wal A.C., Becker A.E., van den Loos C.M. i wsp.: Site of intimal rapture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation, 1994, 89, 36-44.
32. de Winter R.I., Bholasingh R., Lijmer J.G. i wsp.: Independent prognostic value of C-reactive protein and troponin I in patients with unstable angina or non-Qwave myocardial infarction, Cardiovasc. Res., 1999, 42, 240-245.